US Stock MarketDetailed Quotes

HCWB HCW Biologics

Watchlist
  • 0.601
  • -0.019-3.06%
Close Jul 22 16:00 ET
  • 0.603
  • +0.002+0.30%
Post 16:08 ET
22.73MMarket Cap-790P/E (TTM)

HCW Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
2,590.14%1.13M
-57.72%2.84M
-1.31%1.32M
-52.84%853.1K
37.18%622.81K
-98.66%41.88K
6.72M
1.34M
1.81M
454K
Operating revenue
2,590.14%1.13M
-57.72%2.84M
-1.31%1.32M
-52.84%853.1K
37.18%622.81K
-98.66%41.88K
--6.72M
--1.34M
--1.81M
--454K
Cost of revenue
1,644.34%511.97K
-44.84%2.28M
-0.17%1.07M
-53.13%678.33K
74.93%502.4K
-97.79%29.35K
4.14M
1.07M
1.45M
287.2K
Gross profit
4,805.03%614.75K
-78.33%560.36K
-5.84%252.65K
-51.69%174.78K
-27.81%120.41K
-99.30%12.53K
2.59M
268.3K
361.81K
166.8K
Operating expense
50.91%8.11M
48.75%26.28M
85.68%11.02M
19.88%5.25M
25.91%4.63M
46.39%5.37M
32.15%17.67M
90.70%5.94M
7.07%4.38M
33.69%3.68M
Selling and administrative expenses
94.16%5.92M
63.79%13.08M
29.24%3.56M
107.10%3.52M
74.42%2.95M
65.21%3.05M
60.55%7.99M
73.79%2.75M
25.05%1.7M
66.32%1.69M
-General and administrative expense
94.16%5.92M
63.79%13.08M
29.24%3.56M
107.10%3.52M
74.42%2.95M
65.21%3.05M
60.55%7.99M
73.79%2.75M
25.05%1.7M
66.32%1.69M
Research and development costs
-5.87%2.12M
-17.80%7.68M
-27.09%2.14M
-37.05%1.67M
-17.93%1.62M
26.05%2.26M
14.25%9.34M
97.53%2.93M
-1.43%2.65M
17.73%1.97M
Depreciation amortization depletion
-3.08%67.08K
-21.18%266.76K
-69.17%78.31K
97.51%63.08K
282.51%64.8K
94.39%69.21K
54.92%338.46K
453.07%253.97K
-28.74%31.94K
-72.27%16.94K
-Depreciation and amortization
-3.08%67.08K
-21.18%266.76K
-69.17%78.31K
97.51%63.08K
282.51%64.8K
94.39%69.21K
54.92%338.46K
453.07%253.97K
-28.74%31.94K
-72.27%16.94K
Provision for doubtful accounts
----
--5.25M
----
----
----
----
--0
----
----
----
Operating profit
-39.79%-7.49M
-70.55%-25.72M
-90.01%-10.77M
-26.33%-5.08M
-28.47%-4.51M
-185.01%-5.36M
-12.80%-15.08M
-82.08%-5.67M
1.77%-4.02M
-27.63%-3.51M
Net non-operating interest income expense
0
-123.47%-283.04K
101.51%1.42K
-196.77%-95.51K
-95.51K
-93.44K
-126.66K
83.32%-94.48K
-1,167.09%-32.18K
0
Non-operating interest expense
--0
123.47%283.04K
-101.51%-1.42K
196.77%95.51K
--95.51K
--93.44K
--126.66K
--94.48K
--32.18K
--0
Other net income (expense)
-93.32%25.6K
230.10%1.01M
-74.86%86.24K
70.55%234.75K
58,352.52%301.62K
317.31%383.32K
-39.70%304.74K
342.97K
137.65K
516
Other non- operating income (expenses)
-93.32%25.6K
230.10%1.01M
-74.86%86.24K
70.55%234.75K
58,352.52%301.62K
317.31%383.32K
-39.70%304.74K
--342.97K
--137.65K
--516
Income before tax
-47.28%-7.47M
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
4.41%-3.91M
-27.64%-3.51M
Income tax
Net income
-47.28%-7.47M
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
4.41%-3.91M
-27.64%-3.51M
Net income continuous Operations
-47.28%-7.47M
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
4.41%-3.91M
-27.64%-3.51M
Minority interest income
Net income attributable to the parent company
-47.28%-7.47M
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
4.41%-3.91M
-27.64%-3.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-47.28%-7.47M
-67.74%-24.99M
-97.10%-10.68M
-26.17%-4.94M
-22.61%-4.3M
-146.48%-5.07M
-15.85%-14.9M
-70.75%-5.42M
4.41%-3.91M
-8.58%-3.51M
Basic earnings per share
-42.86%-0.2
-66.67%-0.7
-100.00%-0.3
-27.27%-0.14
-20.00%-0.12
-133.33%-0.14
39.13%-0.42
-69.07%-0.15
21.43%-0.11
-5.94%-0.1
Diluted earnings per share
-42.86%-0.2
-66.67%-0.7
-100.00%-0.3
-27.27%-0.14
-20.00%-0.12
-133.33%-0.14
39.13%-0.42
-69.07%-0.15
21.43%-0.11
-5.94%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 2,590.14%1.13M-57.72%2.84M-1.31%1.32M-52.84%853.1K37.18%622.81K-98.66%41.88K6.72M1.34M1.81M454K
Operating revenue 2,590.14%1.13M-57.72%2.84M-1.31%1.32M-52.84%853.1K37.18%622.81K-98.66%41.88K--6.72M--1.34M--1.81M--454K
Cost of revenue 1,644.34%511.97K-44.84%2.28M-0.17%1.07M-53.13%678.33K74.93%502.4K-97.79%29.35K4.14M1.07M1.45M287.2K
Gross profit 4,805.03%614.75K-78.33%560.36K-5.84%252.65K-51.69%174.78K-27.81%120.41K-99.30%12.53K2.59M268.3K361.81K166.8K
Operating expense 50.91%8.11M48.75%26.28M85.68%11.02M19.88%5.25M25.91%4.63M46.39%5.37M32.15%17.67M90.70%5.94M7.07%4.38M33.69%3.68M
Selling and administrative expenses 94.16%5.92M63.79%13.08M29.24%3.56M107.10%3.52M74.42%2.95M65.21%3.05M60.55%7.99M73.79%2.75M25.05%1.7M66.32%1.69M
-General and administrative expense 94.16%5.92M63.79%13.08M29.24%3.56M107.10%3.52M74.42%2.95M65.21%3.05M60.55%7.99M73.79%2.75M25.05%1.7M66.32%1.69M
Research and development costs -5.87%2.12M-17.80%7.68M-27.09%2.14M-37.05%1.67M-17.93%1.62M26.05%2.26M14.25%9.34M97.53%2.93M-1.43%2.65M17.73%1.97M
Depreciation amortization depletion -3.08%67.08K-21.18%266.76K-69.17%78.31K97.51%63.08K282.51%64.8K94.39%69.21K54.92%338.46K453.07%253.97K-28.74%31.94K-72.27%16.94K
-Depreciation and amortization -3.08%67.08K-21.18%266.76K-69.17%78.31K97.51%63.08K282.51%64.8K94.39%69.21K54.92%338.46K453.07%253.97K-28.74%31.94K-72.27%16.94K
Provision for doubtful accounts ------5.25M------------------0------------
Operating profit -39.79%-7.49M-70.55%-25.72M-90.01%-10.77M-26.33%-5.08M-28.47%-4.51M-185.01%-5.36M-12.80%-15.08M-82.08%-5.67M1.77%-4.02M-27.63%-3.51M
Net non-operating interest income expense 0-123.47%-283.04K101.51%1.42K-196.77%-95.51K-95.51K-93.44K-126.66K83.32%-94.48K-1,167.09%-32.18K0
Non-operating interest expense --0123.47%283.04K-101.51%-1.42K196.77%95.51K--95.51K--93.44K--126.66K--94.48K--32.18K--0
Other net income (expense) -93.32%25.6K230.10%1.01M-74.86%86.24K70.55%234.75K58,352.52%301.62K317.31%383.32K-39.70%304.74K342.97K137.65K516
Other non- operating income (expenses) -93.32%25.6K230.10%1.01M-74.86%86.24K70.55%234.75K58,352.52%301.62K317.31%383.32K-39.70%304.74K--342.97K--137.65K--516
Income before tax -47.28%-7.47M-67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M4.41%-3.91M-27.64%-3.51M
Income tax
Net income -47.28%-7.47M-67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M4.41%-3.91M-27.64%-3.51M
Net income continuous Operations -47.28%-7.47M-67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M4.41%-3.91M-27.64%-3.51M
Minority interest income
Net income attributable to the parent company -47.28%-7.47M-67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M4.41%-3.91M-27.64%-3.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -47.28%-7.47M-67.74%-24.99M-97.10%-10.68M-26.17%-4.94M-22.61%-4.3M-146.48%-5.07M-15.85%-14.9M-70.75%-5.42M4.41%-3.91M-8.58%-3.51M
Basic earnings per share -42.86%-0.2-66.67%-0.7-100.00%-0.3-27.27%-0.14-20.00%-0.12-133.33%-0.1439.13%-0.42-69.07%-0.1521.43%-0.11-5.94%-0.1
Diluted earnings per share -42.86%-0.2-66.67%-0.7-100.00%-0.3-27.27%-0.14-20.00%-0.12-133.33%-0.1439.13%-0.42-69.07%-0.1521.43%-0.11-5.94%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg